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An essential property of vascular endothelial cells is the maintenance of a com-
plete hemocompatible monolayer (1). Preserving the integrity of this monolayer re-
quires that cell-cell contacts are established and maintained during the normal cycles
ofendothelial turnover. These contacts develop through adhesion molecules expressed
on the cell surface, including ubiquitous integrin receptors for fibronectin, vitronectin,
collagen, and laminin, and endothelial-specific molecules such as hec7 (2).
To define further endothelial cell adhesion molecules, we generated mAbs against
proliferating human umbilical vein endothelial cells (HUVEC) (3) and used them
to screen HUVEC cDNA libraries transiently expressed in COS cells (4). One of
these mAbs, designated 9G11, recognized a 140-kD surface glycoprotein strongly
expressed at cell-cell contacts. Clones encoding 9G11 epitopes were isolated, and
sequence analysis revealed that this 9G11 endothelial antigen was identical to the
previously identified leukocyte antigen CD31 (D. Simmons, unpublished observa-
tions). CD31 is a widely distributed, single-chain glycoprotein of mass 130-140 kD
found on leukocytes (T and B cells, monocytes, granulocytes, platelets, 4070 ofbone
marrow cells), endothelial, and smooth muscle cells (5).
Here, we report the complete sequence ofCD31/9G11 and show that it is a member
of the Ig superfamily (6). The extracellular domain of CD31 contains four contig-
uous C2-like Ig domains and is most closely related to the intercellular adhesion
molecule carcinoembryonic antigen (CEA) (7, 8).
Materials and Methods
BriefDefinitive Report
Cell Culture, Generation of mAbs, and Immunofluorescence Staining.
￿
HUVEC were established
from freshly isolated full-term umbilical cords and cultured using standard methods (3). All
cell lines were obtained from the ICRF cell bank and grown in DMEM/1070 FCS. mAbs
against HUVEC were generated using a modification ofexisting methods (9). Actively prolifer-
ating HUVEC were used as the immunogen. HUVEC were stained with mAb 9G11 or an
anti-ICAM-1 mAb, RR1, followed by goat anti-mouse FITC conjugate, fixed in PBS/27o
formaldehyde, and photographed on an Axioskop microscope (Carl Zeiss, Inc., Thornwood,
NY) with Ilford 400 ASA film.
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Library Construction and Screening.
￿
cDNA libraries were constructed from mRNA isolated
from HUVEC grown under two types of conditions; unstimulated/proliferating, and acti-
vated for 4 h with a combination ofTNF at 10 ng/ml and IL-1a at 100 ng/ml. HUVECcDNA
was cloned into the expression vector CDM8 (10). An existingcDNA library (11), constructed
from RNA prepared from HL60 cells (promyelocytic leukemia) induced with PMA and cloned
into the irH3M vector (4), was used to isolate CD31 cDNA clones.
To isolate cDNA clones encoding surface molecules, the library was transiently expressed
in COS cells (4), and cells expressing endothelial markers were panned using the anti-HUVEC
mAb 9G11 as a tissue culture supernatant at 1 :10 dilution. Anti-CD31 mAbs SG134 and TM3,
both murine IgGI, were obtained from Dr. D. Y. Mason, John Radcliffe Hospital, Oxford,
and the platelet panel of CD31 mAbs from the Fourth Leukocyte Typing Workshop (Vienna,
1989).
Blot Hybridizations and DNA Sequencing.
￿
RNA was prepared from various cell lines and
20 hg of total RNA loaded per lane, denatured in formaldehyde, subjected to electrophoresis
in 1 % agarose gels, transferred to Hybond N nylon, crosslinked in a Stratalinker, and hybrid-
ized with a random-primed 9G11.3 probe (4, 11). Human genomic DNA was prepared from
a full-term placenta, cut with stated restriction enzymes, subjected to electrophoresis in 1%
agarose, and transferred to nylon in alkaline conditions. Blots were hybridized in Church/
Gilbert buffer with random-primed 9G11 .3 probe (4, 11). Double-stranded sequencing was
carried out by dideoxy chain termination using Sequenase (4, 11). Both strands were sequenced
using a combination of sequence specific oligonucleotide primers and Pst I subclones. Cer-
tain regions were resequenced using deazaguanidine nucleotides substituted for dGTP.
Results and Discussion
To identify novel adhesion molecules expressed on human endothelial cells, a set
of mAbs were generated against HUVEC and screened for surface staining pat-
terns. One of these mAbs, designated 9G11, gave a distinctive pattern in immu-
nofluorescence assays on cultured endothelial cells. 9Gi1 staining was punctate and
localized to cell margins and regions of cell-cell contacts. By contrast, ICAM-1 staining
was diffuse and spread over the whole cell surface (Fig. 1, a and b). This suggested
that the 9G11 antigen may be involved in cell-cell or cell-matrix contacts.
To isolate cDNA clones encoding the 9G11 antigen, cDNA libraries were constructed
from HUVEC either actively proliferating or stimulated with TNF and IL-10, and
screened by transient expression in COS cells (4) using the mAb 9G11. After three
rounds ofexpression and selection, 6 of 10 final round miniprep transfectants scored
positive for surface staining with 9G11 . One of these clones, 9G11 .3 with the largest
insert (2.4 kb) was pursued further.
Preliminary sequence analysis (see below) revealed that the 5' end of the 9G11.3
clone was identical to the Tend of a cDNA clone encoding the CD31 antigen previ-
ouslyisolated from a PMA-stimulated HL60 library using the anti-CD31 mAbs SG134
and TM3 (D. Simmons, unpublished observations) . In addition, COS cells trans-
fected with the 9G11 .3 cDNA clone gave positive surface immunofluorescence staining
with all but one (5A2 .G5) of the CD31 mAbs from the Fourth Leukocyte Typing
Workshop (data not shown). Positive staining was obtained with mAbs SG134,
CLB/HEC75, PvM 6G2, ES12F11, 5.6E, and CIT. Given the sequence identity and
mAb reactivity profiles of the 9G11.3 and CD31.1 cDNA clones, hereafter, we will
refer to the 9G11 antigen as CD31.
CD31 is expressed in proliferating HUVEC and HUVEC activated with a range
of cytokines including TNF, IL-1(3, and INF-7 plus TNF (Fig. 2). Two CD31 tran-
scripts of -3.5 and -3.7 kb are present in all these states, and none of the cytokines
appear to upregulate CD31 expression significantly. In addition, CD31 transcriptsSIMMONS ET AL .
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FIGURE 1 .
￿
IFA analysis ofCD-
31 . (a) IFA staining pattern of
9G11 mAbon confluent mono-
layer of HUVE cells . (b) IFA
staining pattern ofICAM-1 mAb
(RR1) on confluent HUVEC
monolayer,
were present in U937 cells (promonocytic leukemia)andU937 stimulated with INFy,
and the myeloblastic leukemic line KG1 . No transcripts were present in the mela-
noma lines C32 or G361, the osteosarcoma line HT1080, the erythroleukaemic line
K562, the T cell linesMOLT4 or HPBALL, or theB cell lines Raji, Daudi, orJY .
A sample ofa metastatic colon carcinoma also contained CD31 transcripts . How-
ever, given the high level of CD31 expression in myeloid cell lines, and especially
IFN-y-activated lines, the CD31 detected there could be due to the presence of
infiltrating macrophages expressing CD31 .
The complete nucleotide sequence of the insert in the 9G11 .3 clone consists of
2,442 by with a single long open reading frame of 736 amino acids (Fig . 3 a) . This
sequence is identical to partial sequence obtained for a CD31 .1 cDNA clone previ-
ouslyisolated from aPMA-activated HL60 library using anti-CD31 mAbs from the
Third LeukocyteTyping Workshop (5) . This clonewassubmitted to the Fourth Work-
shop and used as aCOS transfectant to score CD31 mAbs . The predicted polypep-
tide sequence consists of an NH2-terminal signal peptide of 23 residues (potentially2150
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FIGURE 2 .
￿
CD31 RNA expression . RNAblot analysis of20 Wg oftotal RNA isolated from var-
ious cell lines and tissues : lane 1, proliferating HUVEC ; lane 2, HUVEC activated with TNF ;
lane 3, HUVEC activated with IL-1R; lane 4, HUVEC activated with TNF plus IFN-y; lane
5, normal colon ; lane 6, colon carcinoma ; lane 7, melanoma line C32 ; lane 8, melanoma line
G361; lane 9, fibrosarcoma line HT1080; lane 10,T cell lineMOLT4; lane 11,T cell lineHPBALL ;
lane 12, promonocytic leukemic line U937 ; lane 13, U937 activated with IFN-'Y (100 U/ml, 12
h); lane 14, myeloblastic leukemic lineKGl; lane 15, erythroleukemic line K562 ; lane 16, B cell
line Raji ; lane 17, B cell line Daudi ; and lane 18, B cell line JY.
cleaved between leucine 23 and glutamic acid 24 [12]), an extracellular domain of
577 residues, a single membrane-spanning region of 19 hydrophobic residues, and
a long cytoplasmic domain of 110 residues . Mature CD31 must be extensively
glycosylated, as the predicted polypeptide mass is only 82 kD, compared with the
observed mass of 130-140 kD . The extracellulardomain contains nine potential sites
(Asn-XSer/Thr) forthe addition ofN-linked carbohydrateandnumerous serine/threo-
nine rich regions for 0-linked sugar attachment .
Comparison (13) of theCD31 polypeptide sequence with theNBRF database (14)
revealed extensive homology to the carcinoembryonic antigen (7), the CEA-related
protein NCA-1 (15), and members of the Ig superfamily (6) . The extracellular do-
main ofCD31 (residues 160-600) contains four contiguous Ig domains of the short
C2 type (N40-50-residue spacing between cysteines) (Fig . 3 b) . Monte Carlo calcu-
lations of the best alignment of CD31 with CEA gives a score of 14.73 SD above
the mean score of the two sequences randomly permutated (16) .
CEA hasrecently been shown to function asahomotypicadhesion molecule when
cDNA clones encoding CEA were expressed in both hamster andhuman cell lines
(8). Given the high degree of sequence and domain similarity between CEA and
CD31, and the distinctive staining pattern of the CD3/9G1 mAbs on HUVEC, we
speculate that CD31 also functions as an ICAM . CD31 may therefore play a role
in maintaining the integrity of the endothelial barrier . In addition, its presence on
leukocyte and tumor cell lines suggests that it may also be involved in interactions
between the vascular endothelium and some circulating cells .a
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G1uG1yG1nGluAsnSerPhoThrIleAsnSerValAspMetLysSerLeu
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PheThrlleG1uLy3LeuGluIeuAanGluLysVatValLyaLeuLy9Ar9GluLysAsnSerArgAapGlMsnPheValIleI*uGluPheProVaIG1uGluGlMspArgVaILeu
SorPhaArgCyaGIMlaArgIleIleSarGlyLeuHisMetGlnThrSerGluSerThrLysSerGluIevValThrValThrGluSerPheSerThrProLy .PheHislI.SerPro
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FIGURE 3.
￿
CD31 sequence analysis and alignment with carcinoembryonic antigen. (a) Predicted
polypeptide sequence of CD31 NH2-terminal signal peptide, potential N-linked glycosylation
sites (Asn-X-Ser/Thr), and COOH-terminal transmembrane domain are underlined (We thank
Dr. Peter Newman for unpublished sequence to aid in our analysis). (b) Alignment of CD31
peptide sequence with carcinoembryonic antigen (CEA, 7) using the ALIGN program (13, 14).
Identities are represented by the residue, similarities by an asterisk. Cysteines involved in poten-
tial Ig domains are boxed.
ESS-RISKVSSIVVNITELFSKPEL
IQNELSVDHSDPVILNVLYGPDDPTI
-ESISGT--LPISYQL
PEAQNTTYLWWVNGQS
E
￿
*T
￿
** Q
C~VNEGSGPITYKFYREKEGKPFYQMTSNATQAFWTKQKASK
-HSASNPSP-QYSWRINGIP-----QQHTQVLFI-AKITP
...S.P
￿
,*
￿
*
￿
*G P
￿
TQ*
￿
,*
￿
*K
Summary
cDNA clones encoding CD31 have been isolated by transient expression. The se-
quence of CD31 expressed on human umbilical vein endothelial cells (HUVEC)
is identicaltothatexpressedonthe monocyte-likecellline HL60. InHUVEC, CD31
is concentrated in regions ofcell-cell contacts. CD31 is a member of the Ig super-
family and is most closely related to the carcinoembryonic antigen CEA, consisting
offourcontiguous C2 domains. The localization ofCD31 to regions ofcell-cellcon-
tacts, and the sequence similarity to CEA, a knownintercellular adhesionmolecule
(ICAM), strongly suggest thatCD31 mayfunction as anICAM, possibly mediating2152
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endothelial cell-cell contacts and also promoting interactions between leukocytes and
endothelial cells.
We thank Dr. Peter Newman for providing unpublished sequence information to aid in our
analysis. Dr. Newman's sequence data have been submitted to the EMBL/GenBank/DDBJ
Data Libraries and have been given the accession number M28526.
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